Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | CNMD | Common Stock | 0 | Feb 24, 2025 | Direct | F1 |
Id | Content |
---|---|
F1 | Remarks: Mark Kaye became a Director of Conmed on February 24, 2025 |